VCM
EW icon

Voleon Capital Management’s Edwards Lifesciences EW Stock Holding History

Voleon Capital Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-4,512
Closed -$353K – 897
2025
Q2 		$353K Sell
4,512
-10,193
-69% -$760K 0.02% 378
2025
Q1 		$1.07M Buy
+14,705
New +$1.05M 0.08% 193
2020
Q1 		– Sell
-63,000
Closed -$4.9M – 52
2019
Q4 		$4.9M Sell
63,000
-60,000
-49% -$4.69M 0.28% 62
2019
Q3 		$9.02M Buy
123,000
+108,000
+720% +$7.59M 0.69% 38
2019
Q2 		$924K Buy
+15,000
New +$907K 0.05% 165

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

Voleon Capital Management's EW Position: Q3 2025 in Review

Voleon Capital Management sold out of Edwards Lifesciences (EW) in Q3 2025, closing a stake of 4,512 shares — an estimated $353K sold.

Voleon Capital Management first reported a position in EW in Q2 2019 and held it in 5 quarters. The position peaked at $9.02M in Q3 2019. 1,253 funds tracked by Wall St. Rank hold EW as of Q3 2025.

  • Voleon Capital Management reported no remaining Edwards Lifesciences position as of Q3 2025 after selling out during the quarter.
  • Voleon Capital Management sold 4,512 Edwards Lifesciences shares in Q3 2025, an estimated $353K.
  • Voleon Capital Management first reported a position in Edwards Lifesciences in Q2 2019 and held it in 5 quarters.
  • Voleon Capital Management's Edwards Lifesciences position peaked at $9.02M in Q3 2019.
  • 1,253 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2025.

Based on Voleon Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.